Search
for
Sort by
Research 301–330 of 1000+
- Novel prospectives of shikimic acid and Prunus mume extract for enhancing bioactivity on 5α-reductase and stability in cosmetic patches for acne treatment
- Comparative Efficacy of Oral and Topical 5-Alpha Reductase Inhibitors in Reducing Dihydrotestosterone levels across Men with Androgenetic Alopecia: A Network Meta-Analysis incorporating Post-Hoc Analyses of Randomized Clinical Trial Data
- The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review
- Geographic Influence and Metabolomics-Driven Discovery of 5-Alpha Reductase Inhibitors in Tectona grandis L.f. (Teak) Leaves
- Inhibition of 5-Alpha Reductase Attenuates Cardiac Oxidative Damage in Obese and Aging Male Rats via the Enhancement of Antioxidants and the p53 Protein Suppression
- Adverse effects of the 5-alpha-reductase inhibitor finasteride on Daphnia magna: Endocrine system and lipid metabolism disruption
- 5 Alpha-Reductase Inhibitory Potential of Solanum nigrum Effective for Management of Alopecia
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Inhibitory activities of Puerariae Flos against testosterone 5α-reductase and its hair growth promotion activities
- Finasteride: the first 5 alpha-reductase inhibitor.
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Effects on Steroid 5-Alpha Reductase Gene Expression of Thai Rice Bran Extracts and Molecular Dynamics Study on SRD5A2
- Finasteride: a 5 alpha-reductase inhibitor.
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Fetal alpha 5-reductase Val89Leu mutation is associated with late miscarriage
- Analysis of genetic polymorphisms of steroid 5α-reductase type 1 and 2 genes in Korean men with androgenetic alopecia
- Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-Blockers vs 5-Alpha Reductase Inhibitors
- Immunolocalization of 5α-Reductase Isozymes in Acne Lesions and Normal Skin
- Urinary steroids in women with androgenic alopecia
- Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids
- Exploring the efficacy of testosterone undecanoate in male children with 5α‐reductase deficiency
- Comprehensive Evaluation of <i>Tectona grandis</i> L.f.: Integrated <i>In Vitro</i> and <i>In Silico</i> Analysis of Steroid 5α-Reductase Inhibition and Anti-Inflammatory Properties
- Dermatology of androgen-related disorders
- ACNE
- New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia